Persistence of Müllerian duct syndrome: a new AMH mutation discovered in a primary infertility case
Reproductive BioMedicine Online · 2025
DOI: 10.1016/j.rbmo.2024.104494 ↗Kurz gefasst
Fallbericht in der Zeitschrift Reproductive BioMedicine Online, 2025. Verfasst von M Navarro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Reproductive Medicine, Pitie-Salpetriere Hospital, Greater Paris University Hospitals (AP-HP), Paris, France. Hauptthemen laut MEDLINE: Disorder of Sex Development, 46,XY, Anti-Mullerian Hormone, Infertility, Male. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Persistent Müllerian duct syndrome (PMDS) is a rare autosomal recessive syndrome characterized by the coexistence of Müllerian derivatives in a normally virilized male, caused by mutations in the AMH or AMHR2 gene. This paper reports the case of a 33-year-old man with PMDS, diagnosed late during an infertility check-up. Exploratory laparoscopy revealed two intra-pelvic gonads and Müllerian duct structures. Genetic analysis identified an undescribed homozygous missense mutation in the fifth exon of AMH. Typically, PMDS is diagnosed in the presence of cryptorchidism or inguinal hernia, and rarely in the context of infertility. Early orchidopexy is recommended to mitigate fertility sequelae while preserving endogenous hormone secretion. This late diagnosis of PMDS led to a discussion of the management of infertility, surgical strategies and adult follow-up. In this case, the decision was made with the patient to perform minimally invasive surgery, specifically unilateral orchidectomy for fertility management. The biopsy revealed no spermatozoa, probably due to prolonged untreated pelvic cryptorchidism. Retaining one testicle maintains endogenous testosterone production, thus avoiding imperfect hormonal replacement. Given the risk of tumoural degeneration, albeit a low one, annual imaging follow-up is mandatory and removal of Müllerian structures and gonadectomy may be considered if necessary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Reproductive Medicine, Pitie-Salpetriere Hospital, Greater Paris University Hospitals (AP-HP), Paris, France.
- Department of Molecular Genetics, Pharmacogenomics and Hormonology, Bicêtre Hospital, Greater Paris University Hospitals (AP-HP), Le Kremlin-Bicêtre, France.
- Department of Anatomic Pathology, Centre Hospitalier Intercommunal de Créteil, Creteil, France.
- Department of Radiology, Centre Hospitalier Intercommunal de Créteil, Creteil, France.
- Department of Endocrinology, Henri Mondor Hospital, Greater Paris University Hospitals (AP-HP), Creteil, France.
- Department of Reproductive Medicine, Gynecology and Obstetrics, Centre Hospitalier Intercommunal de Créteil, Creteil, France.
Zitieren
APA
Navarro, M., Bouligand, J., Kalsoum, S., Pottier, E., Droumaguet, C., Pietin-Vialle, C., Sellam, R., Massin, N., Pasquier, M., & Bry-Gauillard, H. (2025). Persistence of Müllerian duct syndrome: a new AMH mutation discovered in a primary infertility case. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2024.104494
Vancouver
Navarro M, Bouligand J, Kalsoum S, Pottier E, Droumaguet C, Pietin-Vialle C, et al. Persistence of Müllerian duct syndrome: a new AMH mutation discovered in a primary infertility case. Reproductive BioMedicine Online. 2025. doi:10.1016/j.rbmo.2024.104494
BibTeX
@article{Navarro2025,
author = {Navarro, M and Bouligand, J and Kalsoum, S and Pottier, E and Droumaguet, C and Pietin-Vialle, C and Sellam, R and Massin, N and Pasquier, M and Bry-Gauillard, H},
title = {Persistence of Müllerian duct syndrome: a new AMH mutation discovered in a primary infertility case},
journal = {Reproductive BioMedicine Online},
year = {2025},
doi = {10.1016/j.rbmo.2024.104494}
}
EUVIMED